Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
22.90
-0.08 (-0.35%)
Sep 6, 2026, 2:23 PM AST

TADAWUL:9620 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
22.0420.3819.8618.0317.01
Revenue Growth
9.82%2.62%10.11%6.04%-
Cost of Revenue
14.612.5811.569.878.7
Gross Profit
7.447.798.298.178.31
Selling, General & Admin
5.765.293.64.154.68
Other Operating Expenses
-----0.11
Operating Expenses
5.725.293.183.824.58
Operating Income
1.722.55.124.343.73
Interest Expense
-0.08-0.06-0.07-0.09-0.1
Other Non Operating Income (Expenses)
0.280.02---
Pretax Income
1.932.465.044.263.63
Income Tax Expense
0.50.490.260.10.12
Net Income
1.431.974.784.163.51
Net Income to Common
1.431.974.784.163.51
Net Income Growth
-69.54%-58.84%14.85%18.47%-
Shares Outstanding (Basic)
3331-
Shares Outstanding (Diluted)
3331-
Shares Change
-9.09%-69.42%--
EPS (Basic)
0.570.791.912.82-
EPS (Diluted)
0.570.791.912.82-
EPS Growth
-66.75%-58.84%-32.21%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-4.74-7.15.27-1.744.53
Free Cash Flow Per Share
-1.89-2.842.11-1.18-
Dividend Per Share
--1.500--
Dividend Growth
-----
Gross Margin
33.76%38.24%41.76%45.29%48.87%
Operating Margin
7.81%12.28%25.77%24.09%21.95%
Profit Margin
6.48%9.65%24.07%23.08%20.66%
Free Cash Flow Margin
-21.49%-34.82%26.55%-9.65%26.61%
EBITDA
2.753.436.055.174.63
EBITDA Margin
12.49%16.81%30.45%28.65%27.25%
D&A For EBITDA
1.030.920.930.820.9
EBIT
1.722.55.124.343.73
EBIT Margin
7.81%12.28%25.77%24.09%21.95%
Effective Tax Rate
25.86%20.05%5.24%2.27%3.32%
Advertising Expenses
-0.630.430.360.17